Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor

E Rapizzi, ML Taddei, T Fiaschi, C Donati… - Cellular and Molecular …, 2009 - Springer
E Rapizzi, ML Taddei, T Fiaschi, C Donati, P Bruni, P Chiarugi
Cellular and Molecular Life Sciences, 2009Springer
Abstract Sphingosine 1-phosphate (S1P) is a bioactive lipid that acts through a family of G-
protein-coupled receptors. Herein, we report evidence of a novel redox-based cross-talk
between S1P and insulin signaling pathways. In skeletal muscle cells S1P, through
engagement of its S1P 2 receptor, is found to produce a transient burst of reactive oxygen
species through a calcium-dependent activation of the small GTPase Rac1. S1P-induced
redox-signaling is sensed by protein tyrosine phosphatase-1B, the main negative regulator …
Abstract
Sphingosine 1-phosphate (S1P) is a bioactive lipid that acts through a family of G-protein-coupled receptors. Herein, we report evidence of a novel redox-based cross-talk between S1P and insulin signaling pathways. In skeletal muscle cells S1P, through engagement of its S1P2 receptor, is found to produce a transient burst of reactive oxygen species through a calcium-dependent activation of the small GTPase Rac1. S1P-induced redox-signaling is sensed by protein tyrosine phosphatase-1B, the main negative regulator of insulin receptor phosphorylation, which undergoes oxidation and enzymatic inhibition. This redox-based inhibition of the phosphatase provokes a ligand-independent trans-phosphorylation of insulin receptor and a strong increase in glucose uptake. Our results propose a new role of S1P, recognizing the lipid as an insulin-mimetic cue and pointing at reactive oxygen species as critical regulators of the cross-talk between S1P and insulin pathways. Any possible implication of S1P-directed insulin signaling in diabetes and insulin resistance remains to be established.
Springer